Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Pembrolizumab for Advanced NSCLC and PS 2-3

Press/Media

Period	21 Oct 2022

Media coverage

Title	Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Pembrolizumab for Advanced NSCLC and PS 2-3
Media name/outlet	India Pharma News
Country/Territory	India
Date	21/10/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66NW-0921-DXMP-K32T-00000-00
Persons	Deborah Doroshow